Dr. Humphreys is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2016 S Main St
Maryville, MO 64468Phone+1 660-562-2525Fax+1 660-562-7961
Education & Training
- University of Missouri-ColumbiaResidency, Orthopaedic Surgery, 1985 - 1989
- University of Missouri-ColumbiaInternship, Orthopaedic Surgery, 1984 - 1985
- University of Missouri-Columbia School of MedicineClass of 1984
Certifications & Licensure
- MO State Medical License 1984 - 2022
Publications & Presentations
PubMed
- 412 citationsDiscovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 DiabetesWei Meng, Bruce A. Ellsworth, Alexandra A. Nirschl, P.J. McCann, Manorama Patel
Journal of Medicinal Chemistry. 2008-02-09 - 91 citationsThe influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitusSreeneeranj Kasichayanula, Xiaoni Liu, Melanie Pe Benito, Ming Yao, Marc Pfister
British Journal of Clinical Pharmacology. 2013-09-01 - 97 citationsDiscovery of Aminothiazole Inhibitors of Cyclin-Dependent Kinase 2: Synthesis, X-Ray Crystallographic Analysis, and Biological ActivitiesKyoung S. Kim, S. David Kimball, Raj N. Misra, Rawlins David B, John T. Hunt
Journal of Medicinal Chemistry. 2002-08-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: